RecruitingNCT06814431
Study on the Incidence of Malignant Neoplasms in Patients with Parkinson's Disease and Heterozygous Mutation of the GBA Gene
Studying Genetic neurodegenerative disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
- Enrollment
- 3000 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (4)
- Ospedale A. Perrino, Brindisi, Italy
- IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Italy
- Ospedale Santa Chiara di Trento, Trento, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06814431 on ClinicalTrials.govOther trials for Genetic neurodegenerative disease
Additional recruiting or active studies for the same condition.